Showing 5671-5680 of 8159 results for "".
- Another FDA Nod for SkinStylus Microneedling Device: Facial Acne Scarshttps://practicaldermatology.com/news/another-fda-nod-for-skinstylus-microneedling-device-facial-acne-scars/2461904/
- AAD, Janssen, and Kenvue Mentor Next Generation of Dermatologistshttps://practicaldermatology.com/news/aad-janssen-and-kenvue-mentor-next-generation-of-dermatologists/2461884/As part of
- AI in Action: Perfect Corp. Debuts New Skin Type Detection Technologyhttps://practicaldermatology.com/news/ai-in-action-perfect-corp-debuts-new-skin-type-detection-technology/2461883/
- Soligenix, Inc.’s SGX302 (Synthetic Hypericin) Demonstrates “Clear Biological Signal” in Phase 2a PsO Studyhttps://practicaldermatology.com/news/sgx302-synthetic-hypericin-demonstrates-clear-biological-signal-in-phase-2a-pso-study/2461854/Soligenix, Inc.’s SGX302 (synthetic hypericin) showed a clear
- AI In Action: Rubedo Life Sciences Introduces RLS-1496 as a Potential First-in-Class Derm Drughttps://practicaldermatology.com/news/ai-in-action-rubedo-life-sciences-introduces-rls-1496-as-a-potential-first-in-class-derm-drug/2461699/Rubedo Life Sciences has nominated RL
- New Class of Immunotherapy Drugs May Fight Melanomahttps://practicaldermatology.com/news/new-class-of-immunotherapy-drugs-may-fight-melanoma/2461682/A new class of immunotherapy shows promising results for fighting melanoma, a new study shows. The study, published in Nature Communications by researchers from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, investigates whether a n
- First Patient Dosed in Phase 2 Trial of ADX-629 in ADhttps://practicaldermatology.com/news/first-patient-dosed-in-phase-2-trial-of-adx-629-in-ad/2461650/Aldeyra Therapeutics, Inc.
- PHC Corporation, NovaScan Collab Set to Explore NMSC Detection Devicehttps://practicaldermatology.com/news/phc-corporation-novascan-collab-set-to-explore-nmsc-detection-device/2461644/PHC Corporation and
- Researchers Discover Anti-Aging Potential in an Invasive Weedhttps://practicaldermatology.com/news/researchers-discover-anti-aging-potential-in-an-invasive-weed/2461638/The fruit of the cocklebur plant, which grows worldwide and is often considered a noxious weed, has antioxidant and anti-inflammatory components that could make it useful as a skin protectant, according to new research
- LEO Pharma, ICON Enter a Strategic Partnership to Propel Clinical Trial Execution within Dermatologyhttps://practicaldermatology.com/news/leo-pharma-icon-enter-a-strategic-partnership-to-propel-clinical-trial-execution-within-dermatology/2461602/LEO Pharma and